Sort
21,281 grants matching “influenza”
Harnessing Human DC Subsets for Improved Muscosal Vaccines
$4,668,879Yong-Jun Liu · Baylor Research Institute · U19 · FY2012 · AI
JUST-IN-TIME, SINGLE-DOSE, UNIVERSAL ANTI-INFLUENZA A VIRUS THERAPEUTIC
$4,667,205The Leland Stanford Junior University · · FY2018 · Department of the Army
Clinical Trials for Antiviral Therapies
$4,666,629Richard Whitley · University Of Alabama At Birmingham · N01 · FY2010 · AI
Novel Nanoparticle Platform for the delivery of Vaccines and Adjuvants
$4,666,000Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · U19 · FY2017 · AI
Research on the Epidemiology,Prevention,Vaccine Effectiveness and Treatment of Influenza and Other Respiratory Viruses in South Africa.09
$4,656,240Cheryl Cohen · National Health Laboratory Service · U01 · FY2019 · IP
Impact of the Initial Influenza Exposure on the Quality, Magnitude, Breadth, Potency and Durability of Influenza Immunity
$4,655,925Mary A Staat · Cincinnati Childrens Hosp Med Ctr · U01 · FY2019 · AI
Project 4: Protein nanoparticle vaccines
$4,642,108Neil King · University Of Washington · U19 · FY2024 · AI
Conjugate nanoparticle platform development for HIV-1 envelope immunogens
$4,623,440Kevin O Saunders · Duke University · U19 · FY2025 · AI
PanCorVac (Center for Pan-Coronavirus Vaccine Development)
$4,618,169Yoshihiro Kawaoka · University Of Wisconsin-Madison · P01 · FY2023 · AI
Vanderbilt Vaccine and Treatment Evaluation Unit
$4,613,138Clarence Buddy Creech · Vanderbilt University Medical Center · UM1 · FY2021 · AI
Systems Immunogenetics of Biodefense Pathogens in the Collaborative Cross
$4,594,721Ralph S Baric · Univ Of North Carolina Chapel Hill · U19 · FY2012 · AI
Vaccination and infection: indicators of immunological health and responsiveness
$4,579,758Mark M Davis · Stanford University · U19 · FY2010 · AI
Centers of Excellence for Influenza Research and Surveillance
$4,564,499Michael T. Osterholm · University Of Minnesota · N01 · FY2011 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
$4,521,434Walter A. Orens · Emory University · N01 · FY2014 · AI
Novel Nanoparticle Platform for the delivery of Vaccines and Adjuvants
$4,521,374Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · U19 · FY2016 · AI
IP24-045, A Prospective Observational Study of Respiratory Virus Epidemiology in the Greater Boston Area
$4,500,000Kathryn Elaine Stephenson · Beth Israel Deaconess Medical Center · U01 · FY2024 · IP
RFA-IP-24-046: Nationwide Cohort of Blood Donors to Estimate Burden of Respiratory Viruses and Immunologic Response
$4,500,000Michael Paul Busch · Vitalant · U01 · FY2024 · IP
The Infectious Diseases Clinical Research Program (IDCRP)
$4,500,000Timothy Burgess · National Institute Of Allergy And Infectious Diseases · Y01 · FY2021 · AI
Systems Analysis Vaccine Responses in Healthy and Hyporesponsive Humans
$4,499,507Anna Karolina Palucka · Baylor Research Institute · U19 · FY2010 · AI
Epitopes recognized by Influenza and Flavivirus responsive CD4+ T cells
$4,489,824Benaroya Research Inst At Virginia Mason · N01 · FY2009 · AI
Defining signatures for immune responsiveness by functional systems immunology
$4,456,091David A. Hafler · Yale University · U19 · FY2010 · AI
Genomic Sequencing Center for Infectious Diseases
$4,446,907William Charles Nierman · J. Craig Venter Institute, Inc. · N01 · FY2011 · AI
NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities
$4,443,970Richard Webby · St. Jude Children'S Research Hospital · N01 · FY2024 · AI
Impact of the Initial Influenza Exposure on the Quality, Magnitude, Breadth, Potency and Durability of Influenza Immunity
$4,442,677Mary A Staat · Cincinnati Childrens Hosp Med Ctr · U01 · FY2022 · AI
Impact of the Initial Influenza Exposure on the Quality, Magnitude, Breadth, Potency and Durability of Influenza Immunity
$4,441,694Mary A Staat · Cincinnati Childrens Hosp Med Ctr · U01 · FY2021 · AI